chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Dizziness
Clinical narrative: Bad chills; coughing; dizziness or light headed; This is a spontaneous report from a contactable consumer (patient) via a regulatory authority. A 47-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in arm left on 28Feb2021 09:45 (lot number: EN6202; expiry date: unknown) as dose 1, single for Covid-19 immunisation. Medical history included high blood pressure, diabetes 2, high cholesterol, and obesity. Concomitant medications included atenolol and rosuvastatin calcium (ROVASTIN) taken for unspecified indications, start and stop date were not reported. The patient previously received procaine (NOVOCAINE) and experienced allergies. The patient was not pregnant at the time of vaccination. The vaccine was administered in the hospital. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The patient has not been tested for COVID-19 since vaccination. On 02Mar2021 at 15:00, the patient experienced bad chills, coughing, and dizziness or lightheaded. The patient did not receive treatment for the events. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Contusion, Lymphadenopathy, Swelling
Clinical narrative: top of my shoulder is really sore; substantial swelling left side of neck / a lot of swelling between my neck and rotator cuff; front lymph node above collarbone bulging out and looks bruised; looks bruised; This is a spontaneous report from a non-contactable consumer (patient). A 48-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EN6203; Expiration date was not reported), via an unspecified route of administration in the left arm on 24Feb2021 08:00 AM (at the age of 48-years-old) as dose 2, single for COVID-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing. Concomitant medications included Vitamin D and ibuprofen (ADVIL); both taken for an unspecified indication, start and stop dates were not reported. The patient was previously vaccinated with BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EL9269; Expiration date was not reported) via an unspecified route of administration in the left arm on 03Feb2021 08:00 AM (at the age of 48-years-old) as dose 1, single for COVID-19 immunisation. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. The patient has no known allergies. The patient experienced substantial swelling left side of neck, front lymph node above collarbone bulging out and looks bruised on 25Feb2021 08:00 AM (reported as 24 hours after injection). 48 hours after injection, swelling down slightly and still see the lymph node. The patient experienced top of her shoulder was really sore, felt a lot of swelling between her neck and rotator cuff on 26Feb2021 14:00 (54 hours since injection). No treatment was received for the events. The outcome of the events was not recovered. The patient was querying on how she would know if there was permanent damage; patient haven't yet been seen and doesn't mean she won't be if this continues.   No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Pain
Clinical narrative: Severe upper body aches - upper back, right shoulder/pectoral area. Hurts to cough & sneeze.  Taking 600mg motrin to help with pain; Severe upper body aches - upper back, right shoulder/pectoral area. Hurts to cough & sneeze.  Taking 600mg motrin to help with pain; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: en6203, Expiration Date: not reported) via an unspecified route of administration in left arm on 20Feb2021 14:45 as dose 1, single for COVID-19 immunization (at the age of 51-year-old, non-pregnant) . Medical history included thyroid, PCOS, arthritis, obesity. Patient had no allergies. Concomitant medication(s) included sertraline hydrochloride (ZOLOFT); amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); guanfacine; ergocalciferol (VIT D); levothyroxine sodium (LEVOTHROID), z. Patient received other vaccine in four weeks Shingrix via an unspecified route of administration in left arm on 29Jan2021 as dose 1 for an unspecified indication. Patient had no COVID prior vaccination and was not COVID tested post vaccination. The patient experienced severe upper body aches - upper back, right shoulder/pectoral area, hurts to cough & sneeze taking 600mg motrin to help with pain on 22Feb2021. Patient received treatment with 600 mg motrin to help with severe upper body aches - upper back, right shoulder/pectoral area, hurts to cough & sneeze. The outcome of the events was not recovered.  No follow up attempts are possible. Information about Lot/Batch can not be requested. No further information is expected.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Rash, Rash macular
Clinical narrative: Then, pimple type spots on forehead day 5; Large rash area on right cheek 4 days after vaccine; Headaches are ongoing.; This is a spontaneous report from a non-contactable consumer (patient). A non-pregnant 82-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number, and Expiration date were not reported), via an unspecified route of administration on 09Feb2021 16:00 (at the age of 82-years-old), as dose number unknown, single for COVID-19 immunisation. Medical history included dementia, penicillin allergy. Concomitant medications included donepezil; memantine; omeprazole; iron; zinc; unspecified medication (reported as "c"), all taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced large rash area on right cheek 4 days after vaccine, headaches are ongoing on 13Feb2021, then, pimple type spots on forehead day 5 on 14Feb2021. Events resulted to administration of steroids, emergency room, and physician office visit. The outcome of headaches were not recovered while the rest of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Petechiae, Purpura
Clinical narrative: Small red spots on skin like capillary breaks (petechiae and small purpura); Small red spots on skin like capillary breaks (petechiae and small purpura); This is a spontaneous report from a contactable healthcare professional (patient) received via database. A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, on 25Feb2021 at 09:45 AM (Batch/Lot number was not reported) (at the age of 39 years old) as dose number unknown, single for COVID-19 immunisation in a hospital. The patient's medical history was not reported. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient has no known allergies. The patient was not pregnant at the time of vaccination. The patient was taking unspecified concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced painless small red spots on skin like capillary breaks (petechiae and small purpura) on 26Feb2021 at 08:00 AM. It was unknown if the patient received treatment for the events. The outcome of events was unknown.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Tendon pain
Clinical narrative: pain in my left achilles in the ankle area; pain in my left achilles in the ankle area; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age (Age: 73; Unit: Unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 28Feb2021 11:30 (Lot Number: EN6205) as DOSE 2, SINGLE for COVID-19 immunisation. Medical history included BPH, cholesterol and osteoporosis from an unknown date. Concomitant medication(s) included terazosin, atorvastatin (LIPITOR), alendronate sodium (FOSAMAX), ascorbic acid, biotin, folic acid, iodine, pantothenic acid, pyridoxine hydrochloride, retinol, vitamin b12 nos, vitamin d nos, vitamin e nos, zinc (CENTRUM MULTIGUMMIES), ubidecarenone (COQ10) and colecalciferol (VITAMIN D); all taken for an unspecified indication, start and stop date were not reported. The patient previously took BNT162B2 at the age of 73 years old, dose 1 on 07Feb2021 11:30 AM in the left arm lot number: EN5318 for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient stated, "I began having some pain in my left achilles in the ankle area. It started on the day, Sunday on 28Feb2021 16:00. I received the second vaccine and occurred again on Monday, Tuesday and today for a short period of time. I was able to walk on it after getting the pain and it seemed to just go away. I have never had a problem with my achilles before getting the vaccine. I am wondering if it could be a side effect from the vaccine, or just coincidental. I am contacting you to find out if others have experienced this problem following their injections." No treatment given to the patient for the events. The patient has not been COVID-9 tested since the vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Pain in extremity, Paraesthesia
Clinical narrative: Soar arm; taste of iron or metal in my mouth; tingling in arm/fingers; This is a spontaneous report from a contactable consumer (patient) who is a Pfizer colleague. A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EL3247, Expiration Date: not reported), via an unspecified route of administration, administered in left arm on 02Mar2021 at 13:15 (at the age of 39 years old) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination and  prior to vaccination was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and has no list of any other medications received within 2 weeks of vaccination. On 02Mar2021 at 14:00, the patient experienced "Soar arm" (as reported), taste of iron or metal in her mouth and tingling in arm/fingers. No treatment was received for the adverse events. Since vaccination, the patient has not been tested for COVID-19. Outcome of all events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain
Clinical narrative: aching; pain; This is a spontaneous report from a non-contactable consumer (patient). A 73-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on 02Mar2021 (Batch/Lot number was not reported) as dose 2, single (at the age of 73-years-old) for Covid-19 immunisation. Medical history was not reported. There were no concomitant medications. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on unknown date (Batch/Lot number was not reported) as dose 1, single for Covid-19 immunisation. The patient experienced aching, and pain the previous night on 02Mar2021, and that day, she was having some sharp pains. She wanted to know if she can take some Tylenol. The outcome of the events was unknown.   No follow-up attempts are possible; information about batch/lot number cannot be obtained. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Pyrexia
Clinical narrative: chilled; lack of energy; low grade fever for 5 days; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received BNT162B2, via an unspecified route of administration, administered in left arm on 25Feb2021 16:00 (Batch/Lot Number: EL9266) at the age of 68 years old as dose 1, single for covid-19 immunisation. Medical history included blood pressure, cholesterol, anemia, arthritis, all from unknown dates and unknown if ongoing. Patient was not pregnant. There were other (concomitant) medications in two weeks. The patient previously took phenobarbital (known allergies). No other vaccine in four weeks. The patient was chilled, experienced lack of energy and had low grade fever for 5 days (as reported) on 26Feb2021 19:00. No treatment for adverse events. No COVID prior vaccination and not COVID tested post vaccination. Outcome of events were recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Nose bleeds; This is a spontaneous report from a contactable health care professional (patient). A 56-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration, administered in the left arm on 24Feb2021 at 08:30 (Lot Number: EL9267) as dose 1, single for COVID-19 immunization.  The patient did not have any medical history and had no known allergies. The patient did not have COVID prior to vaccination. The patient's concomitant medications were not reported. The patient did not receive other vaccinesin four weeks. The patient was not tested for COVID-19 post vaccination. On 01Mar2021 at 12:00 the patient experienced nose bleeds. The patient did not receive treatment for the event. The outcome of the event was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching in arms, chest, back, head, and face; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 78-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was not reported), via an unspecified route of administration in left arm, on 02Mar2021 at 08:00 AM (at the age of 78 years), as dose 1, single, for COVID-19 immunization. The patient's medical history included high blood pressure, sinus issues, and allergies to sulfa and avocado. The patient's concomitant medications included zolpidem tartrate (AMBIEN), valsartan (VALSART), and gabapentin. The patient previously took morphine and experienced allergies. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a health clinic facility. On 02Mar2021 at 01:15 PM, the patient experienced itching in arms, chest, back, head, and face. No treatment was administered for the event. The patient has not been tested for COVID-19 post vaccination. The patient had not recovered from the event.  No follow-up attempts are possible; information about lot or batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Lymph node pain, Oropharyngeal pain, SARS-CoV-2 test, Skin discharge
Clinical narrative: sore throat; slightly tender lymph nodes; redness; slight exudate; This is a spontaneous report from a contactable physician (patient) through the Pfizer-sponsored program. A 65-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 09Feb2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 02Mar2021, the patient developed a sore throat and had slightly tender lymph nodes in his right anterior neck with redness on the side and slight exudate, with no other symptoms. He got tested for COVID-19 to be sure he did not have it because he did not think this was the case. Outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia
Clinical narrative: muscle pain in my left arm; swelling of the lymph nodes in my left armpit; This is a spontaneous report from a contactable other health professional reported for herself. A 46-Year-old, non-pregnant, black female patient received second dose of BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine, formulation: Solution for injection, lot number: EL 9262) via intramuscularly in Left arm on 29Jan2021 at 10:45 AM (at the age of 46 years) as DOSE 2, SINGLE for COVID-19 immunisation. Medical history included toothache from an unknown date and unknown if ongoing (Advil Duo and amoxicillin for toothache, had a root canal performed 4days after 2nd dose of vaccine), allergies to Walnuts. Concomitant medication(s) included ibuprofen (ADVIL) taken for toothache, start and stop date were not reported; amoxicillin (AMOXICILLIN) taken for toothache, start and stop date were not reported. The patient was performed with a root canal 4days after 2nd dose of vaccine. The concomitant medications included ibuprofen (ADVIL) and amoxicillin for toothache. The patient historical vaccine included BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine, formulation: Solution for injection, lot number: EL-1284) via intramuscularly in Left arm on 08Jan2021at 08:00 AM, as DOSE 1, SINGLE for COVID-19 immunisation. After the first dose, the patient had sporadic muscle nerve pain in left arm and left leg for a few days following the injection. Also experienced headaches during that time. The patient did not diagnose with COVID-19 prior to vaccination. After receiving the second dose of vaccine on 31Jan2021, the patient experienced had muscle pain in my left arm and swelling of the lymph nodes in my left armpit for about 4 days. The patient did not receive treatment. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was recovered on an unspecified date in 2021.  Follow-up attempts completed. No further information expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Feeling pain on the left side of my chest; uncomfortable chest pain after I take my regular medication; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6198), via an unspecified route of administration on 21Feb2021 (at the age of 70-years-old) as dose 2, single for COVID-19 immunisation. The patient's medical history was not reported.  The patient's concomitant medication included an unspecified medication. The patient previously received the first dose of BNT162B2 (Batch/Lot Number: EL9262), on 31Jan2021 for COVID-19 immunisation. The patient was feeling pain on the left side of her chest; uncomfortable chest pain after she takes her regular medication on an unspecified date. Consumer stated, "I am calling because I take both doses, the first dose I didn't have any problem, the second dose however, after about two or three days I start feeling pain on the left side of my chest and during the day I guess, I didn't notice too much because I was doing other things but in the evening you know, I have uncomfortable chest pain after I take my regular medication (further not clarified hence, captured as Unspecified medication), last night it was bad and it is still bothering me right now." When probed for any other help, consumer stated, "No, I registered for, we safe right and then I received it the first time with you know I didn't have any problem and the second one I went in and I think it might re-registration because then I keep them receiving both of them every day. The both can retake every day I receive both of them, so I went in and I stop one but somehow, I stop all of them so it seems then I have not receive any then we safe checked. So, I just registered again before you call me. Is it hope you got some answer to me because I do have a concern and I don't feel very comfortable." Consumer further stated, "I am just wondering if that's you know one of the I know that's you know this is very unusual other reaction and side effect putting to you so I just wondering you know if this it is side effects from the vaccines I received." The outcome of the event was unknown.    No follow up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: severe itching on thighs and lower back; This is a spontaneous report from a contactable consumer. A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 01Mar2021 15:00 at the age of 71-year-old (Batch/Lot number was not reported) as DOSE 2, SINGLE for COVID-19 immunization in the public Health Clinic/Veterans. The patient was not pregnant at time of vaccination. Medical history included macular degeneration, abdominal hernia, hypertension and e-cadherin and p120 breast tumor recently diagnosed; all from an unknown date. The patient previously took aspirin and vancomycin and experienced allergy. The patient previously had BNT162B2 on 08-FEB-2021 16:00 dose 1, single in the left arm for COVID-19 immunization. The patient experienced severe itching on thighs and lower back on 01Mar2021 20:00. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was taking goli - apple cider vinegar gummies concmitantly. No treatment given for the event.The patient has not been COVID-9 tested since the vaccination. The patient was not diagnosed with COVID-19 prior to vaccination The outcome of events was recovered on unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.  .
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: still in pain from joints and muscles; still in pain from joints and muscles; This is a spontaneous report from a contactable consumer (patient).  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6205), via an unspecified route of administration on 25Feb2021 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported that he/she had the shot on 25Feb2021 and he/she was still in pain from joints and muscles which started on an unspecified date. Outcome of pain from joints and muscles was unknown.    No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Eye swelling, Swelling face
Clinical narrative: bilateral Facial swelling; eyes looked pretty swollen; This is a spontaneous report from a contactable pharmacist (patient's son). A 78-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and Expiration Date: not reported), via an unspecified route of administration on 23Feb2021 at 13:40 (at the age of 78 years old) as dose 1, single for COVID-19 immunisation. Medical history included COVID-19 (positive by a COVID-19 Virus nasal swab test) from Nov2020 to an unknown date; coronary artery bypass and coronary arterial stent placement, MI (myocardial infarction) and stroke - all from an unknown date. The reporter clarified he was younger when the patient had either the MI (myocardial infarction) or stroke in the past, so he does not have any further information. The patient's concomitant medications were not reported. The patient has no history of all previous immunization with the Pfizer vaccine considered as suspect and did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Feb2021, the patient had facial swelling. The reporter clarified that the patient had bilateral facial swelling. The reporter had "face-timed" with the patient on the morning of the report and the patient's eyes looked pretty swollen, too. The reporter said that the patient had no itching nor shortness of breath. The events did not require visit to emergency room nor a physician office visit. The reporter believed that the patient may have self-medicated with a paracetamol (TYLENOL 500mg tablet) in response to the events. The patient did not recover from both events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest pain, Chills, Headache, Heart rate
Clinical narrative: weakness; headache; chest pain; rapid heart beat; Chills; fever; swollen throat; body ache; This is a spontaneous report from a contactable other hcp.     A 28-years-old female Non-Pregnant patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 24Feb2021 11:45 as dose 2, single dose for covid-19 immunisation.The patient medical history was not reported. Concomitant medication(s) included phentermine (PHENTERMINE).The patient was not pregnant at the time of vaccination. The patient had not known allergies. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. Patient previously took first dose of bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration,(Batch/Lot Number was Not Reported) as single dose for covid-19 immunisationIt was Reported that, the patient experienced chills, fever, swollen throat, body ache, weakness, headache, chest pain on 24Feb2021, rapid heartbeat on 24Feb2021 23:00 with outcome of recovered with sequelae.The patient underwent lab tests and procedures which included heart rate: rapid on 24Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Pain, Pharyngeal swelling, Pyrexia
Clinical narrative: weakness; headache; chest pain; rapid heart beat; Chills; fever; swollen throat; body ache; This is a spontaneous report from a contactable other hcp.     A 28-years-old female Non-Pregnant patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 24Feb2021 11:45 as dose 2, single dose for covid-19 immunisation.The patient medical history was not reported. Concomitant medication(s) included phentermine (PHENTERMINE).The patient was not pregnant at the time of vaccination. The patient had not known allergies. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. Patient previously took first dose of bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration,(Batch/Lot Number was Not Reported) as single dose for covid-19 immunisationIt was Reported that, the patient experienced chills, fever, swollen throat, body ache, weakness, headache, chest pain on 24Feb2021, rapid heartbeat on 24Feb2021 23:00 with outcome of recovered with sequelae.The patient underwent lab tests and procedures which included heart rate: rapid on 24Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Rash pruritic
Clinical narrative: has a rash from her elbow to her wrist with little bumps that are itchy, also on her left arm; having trouble lifting left arm; This is a spontaneous report from a contactable consumer (patient) received from a Call Center. A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in left arm on 24Feb2021 at 14:00 (Batch/Lot number was not reported) (at the age of 71-years-old) as dose 1, single for COVID-19 immunisation. The patient had no medical history. The patient had no concomitant medications. The patient experienced having trouble lifting left arm on 24Feb2021 and had a rash from her elbow to her wrist with little bumps that are itchy, also on her left arm on 26Feb2021. The outcome of events was recovering.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itching was worse; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the right arm on 23Feb2021 (Lot Number: EN6202) as dose 2, single for COVID-19 immunisation.  Medical history included type 2 diabetes, hypertension, and osteoarthritis. The patient was not pregnant at the time of the events. Concomitant medications included topiramate, losartan, ibuprofen, propranolol, and vita. The patient previously took the first dose of BNT162B2 (Lot Number: EL0264) administered in the right arm on 01Feb2021 at 16:00 for COVID-19 immunisation and experienced systemic itching. On an unspecified date, the patient experienced itching was worse second time, but tolerable. The outcome of the event was unknown.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Rash, Swollen tongue
Clinical narrative: Tongue swelling; flushed with rash right after vaccine; flushed with rash right after vaccine; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number and Expiration date were not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced tongue swelling and flushed with rash right after vaccine. It was reported that the patient took PREGNAZON after the vaccine and everything calmed but the ER physician that she saw told her to take the it again in the morning and the swelling returned. The outcome of the events was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Throat irritation, Vaccination site pain
Clinical narrative: hurting on her arm/ the hurting in her arm was the same arm she got her COVID vaccine, which was the left arm; tickle in her throat; cough; This is a spontaneous report from a Pfizer sponsored program,  Support. A contactable consumer (patient) reported that a 76-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in the left arm on 25Feb2021, at 14:30 or 15:00 (as reported) (Lot Number: EN6205; at the age of 76 years old) as dose 2, single for COVID-19 immunisation. The patient stated that she knew she had some kind of heart problem but it did not bother her and an eye condition and she was not a very sickly person; she also had two blood clots that were found in the latter part of Nov2020. The patient also took three of the COVID tests over the past 2-3 months and those were negative. Concomitant medication included apixaban (ELIQUIS) taken for blood clots from Nov2020 and ongoing. She did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162B2, via an unspecified route of administration, administered in the left arm on 04Feb2021 (Lot Number: EL9264; at the age of 76 years old) for COVID-19 immunisation and she felt absolutely nothing. On 25Feb2021, the patient experienced hurting on her arm, tickle in her throat, and cough after the shot. She stated that all of this started on 25Feb2021, about two hours after she took the injection. Once she took the shot, she waited 15 minutes to make sure she did not have a reaction and the reported events did not start until about two hours after she took the shot. She reported that she was up all night with her arm hurting and it still was hurting; the hurting in her arm was the same arm she got her COVID vaccine, which was the left arm, and it began hurting the same day she received her shot. She reported that the pain was just a thumping type of hurt when she moved her arm. On 25Feb2021, she also got a tickle in her throat after she got the shot. The tickle in her throat started and she coughed all night and in the morning. It was just something that tickled in her throat and made her cough and she did not know what was going on. She reported that the tickle in her throat was just irritating. The events did not result to a physician office or an emergency room visit. She did not have any treatment because the events just happened, but she stated that she would see a doctor if it were to continue for a few more days or weeks. The patient stated that apixaban did not do anything in terms of side effects while she took the COVID vaccine. At the time of report, the patient has not recovered form the events.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heart rate, Heart rate increased, Pharyngeal swelling
Clinical narrative: slight swelling of throat; dizziness; extremely fast heartbeat; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number, and Expiration date were not reported), via an unspecified route of administration on an unspecified date, as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced slight swelling of throat , dizziness, shortly after getting vaccine and extremely fast heartbeat, 15 hrs after receiving the vaccine, on an unspecified date. The patient underwent lab tests and procedures which included heart rate: increased on an unspecified date. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Mild fever and some fatigue; Mild fever and some fatigue; This is a spontaneous report from a contactable consumer (patient). A 28-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL3248), via an unspecified route of administration on 02Mar2021 at 11:00 (at the age of 28-years-old) at dose 1, single in the left arm for COVID-19 immunization. Medical history included asthma. Concomitant medications included sertraline hydrochloride (ZOLOFT) film-coated tablet and budesonide, formoterol fumarate (SYMBICORT) for asthma. The patient previously took cefaclor (CECLORE) and experienced drug allergy. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19, and since the vaccination, the patient has not been tested for COVID-19. The patient was vaccinated in a workplace clinic. On 02Mar2021, the patient experienced mild fever and some fatigue. No treatment was received for the events. Outcome of the events was recovered on an unspecified date in 2021.   Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: feels so sore today; This is a spontaneous report from a non-contactable consumer (patient) via Pfizer sales representative. A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and expiration date were not reported), via an unspecified route of administration on 25Feb2021 as dose number unknown, single for COVID-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced felt "so sore" on 26Feb2021 (reported as today). The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Rash
Clinical narrative: Rash; Body aches; This is a spontaneous report from a non-contactable other healthcare professional (patient).   A 62-year-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 25Feb2021 13:15, at the age of 62-years-old, (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunization.  Medical history included rash (patient states that he gets a rash whenever he contracts a VIRUS), covid-19 from an unknown date (prior vaccination: yes). The patient's concomitant medications were not reported.  On 27Feb2021 07:00, the patient experienced rash and body aches. The outcome of the events was recovered on 01Mar2021.  The patient was not tested for COVID-19 post vaccination. No treatment was received for the events.     No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Swelling
Clinical narrative: feeling swelling; pain in her neck at the right side of her body; This is a spontaneous report from a Pfizer sponsored program Support. A contactable consumer (patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number, and Expiration date were not reported), via an unspecified route of administration on 26Feb2021, as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced feeling swelling and pain in her neck at the right side of her body on 27Feb2021. Patient wanted to know what she can do about it and if she should be concerned about the symptoms. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Musculoskeletal stiffness
Clinical narrative: joint pain in left index finger; muscle stiffness in left shoulder; This is a spontaneous report from a non-contactable consumer (patient). A 46-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Right on 09Feb2021 (at the age of 46-years-old) as dose 1, single for COVID-19 immunisation. The patient's medical history was not reported.  The patient previously took amoxycillin and had known allergies. The patient experienced joint pain in left index finger and muscle stiffness in left shoulder on 22Feb2021. There was no treatment received for the events. The outcome of the events was not recovered.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Swelling face
Clinical narrative: swollen face; skin turning red; This is a spontaneous report from a Pfizer-sponsored Program. A contactable consumer reported that a male patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on 27Feb2021 (lot number was not reported) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced swollen face and the patient's skin was turning red after the first dose on 27Feb2021. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itching to both legs and back; This is a spontaneous report from a contactable physician via Self-Reporting.  A 69-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular, administered in Arm Left on 16Feb2021 at 11:45 (lot number: EM9810; expiry date: unknown) at the age of 69-years-old, as dose 2, single for Covid-19 immunisation. Medical history included congestive heart failure (CHF), prostate cancer, and hypertension (HTN). The patient had no known allergies. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), for Covid-19 immunisation. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The patient was not diagnosed with COVID prior vaccination. The patient has not been tested for COVID-19 since vaccination. On 16Feb2021, the patient experienced itching to both legs and back. The patient did not receive treatment for the event. Outcome of the event was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Peripheral swelling
Clinical narrative: swelling in upper and low lips and right hand after second dose; swelling in upper and low lips and right hand after second dose; This is the spontaneous report from a contactable consumer (patient). A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration, administered in the left arm, on 08Feb2021 (Batch/lot number: EL3302), at age 38 years old, as dose 2, single, for COVID-19 immunisation, at a workplace clinic. The patient was not pregnant at the time of vaccination. Relevant medical history included gastroesophageal reflux disease (GERD), obesity, temporomandibular joint (TMJ), cameron ulcers, hiatal hernia, and known allergies to sulfa, dust, and some roots, all from unknown dates, not reported if ongoing or not. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. Concomitant medication included omeprazole taken for an unknown indication, start and stop dates not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), received via an unspecified route of administration, administered in the left arm, on 18Jan2021 08:30 (Batch/lot number: EL3302), at age 38 years old, as dose 1, single for COVID-19 immunisation after which the patient experienced swelling in lower lip. The patient did not receive any other vaccine in four weeks. On an unspecified date, the patient experienced swelling in upper and low lips and right hand after the second dose. The events resulted to physician's office visit. Treatment included BENADRYL which did not help and prednisone which helped. The patient recovered from the events on an unspecified date.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose fluctuation, Pyrexia
Clinical narrative: fever; sugar went up and down; This is a spontaneous report from a contactable consumer (patient's wife) received via a Pfizer-sponsored program, Pfizer Patient Assistance and Savings Program. A 68-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, on an unspecified date (Batch/Lot number was not reported) (at the age of 68 years old) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced fever and his sugar went up and down. The patient underwent lab tests and procedures which included sugar (blood glucose): went up and down, on an unspecified date. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Swelling
Clinical narrative: underarm swelled; felt pain in the arm; This is a spontaneous report from a contactable consumer (patient's wife) via a Pfizer-sponsored program. A male patient (husband) of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 25Feb2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  It was reported that the patient received the first dose of the vaccine on 25Feb2021 (Thursday). After receiving the vaccine on 25Feb2021, the patient felt pain in the arm. The following day on 26Feb2021, the patient's underarm swelled. Outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Irritability, Pruritus
Clinical narrative: Itchy; It is really turned red; I got irritated and itchy; really turned red; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on 14Feb2021 (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 14Feb2021, from CDC or an organization, patient got the shot and it was done by Pfizer. Patient was fine all week and the following Sunday, the 23Feb2021, patient stated that it was getting really itchy and it really turned red. So, patient called the primary doctor and went there and the nurse practitioner took a magic marker and circled it and said, let us see if it gets any bigger and that did. So, patient still have the red mark and doesn't know what to use on it, it is not a exactly mark, it is a little saucer like a small circle like the size of cantaloupe and while the doctor chose to give Benadryl but it didn't work. So, then he gave me a hydro cream, it got the hydrocortisone in it (treatment). Patient tried the Benadryl first but couldn't mix the Benadryl with the allergy tablet that physician gave the patient. So, patient still got it and wanted to know if it was normal. Following that, patient got irritated and itchy. The outcome of the event 'really turned red' was not recovered; while for the other events, it was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.